Skip to Main Content

Author Details

Andrew J Lotery
University of Southampton
1994
330
59
PMIDPaper TitleJournal TitlePublished Year
37203782Impact of the ongoing worldwide shortage of verteporfin (Visudyne®) on the visual function of patients with chronic central serous chorioretinopathy.Acta Ophthalmol2024
37806544IMPG2-Related Maculopathy.Am J Ophthalmol2024
37553357Correction: Central macular choriocapillaris impairment as a manifestation of microvascular disease in eyes with subretinal drusenoid deposits.Eye (Lond)2024
37890677Systematic review of prognostic factors associated with progression to late age-related macular degeneration: Pinnacle study report 2.Surv Ophthalmol2024
37542174Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients.Eye (Lond)2024
37673970The role of the retinal vasculature in age-related macular degeneration: a spotlight on OCTA.Eye (Lond)2024
37419959Central macular choriocapillaris impairment as a manifestation of microvascular disease in eyes with subretinal drusenoid deposits.Eye (Lond)2024
35953562Correction: Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocol.Eye (Lond)2023
37624605Comparison of Novel Volumetric Microperimetry Metrics in Intermediate Age-Related Macular Degeneration: PINNACLE Study Report 3.Transl Vis Sci Technol2023
37945665Automated deep learning-based AMD detection and staging in real-world OCT datasets (PINNACLE study report 5).Sci Rep2023
37821525Human equivalent doses of L-DOPA rescues retinal morphology and visual function in a murine model of albinism.Sci Rep2023
35739243Subretinal drusenoid deposits as a biomarker of age-related macular degeneration progression via reduction of the choroidal vascularity index.Eye (Lond)2023
35614343Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocol.Eye (Lond)2023
37386247Large-scale multitrait genome-wide association analyses identify hundreds of glaucoma risk loci.Nat Genet2023
37113474Exploring Healthy Retinal Aging with Deep Learning.Ophthalmol Sci2023
37443742Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment.Cells2023
37355273Cohort profile: rationale and methods of UK Biobank repeat imaging study eye measures to study dementia.BMJ Open2023
36723966Repeatability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients With Recessive Stargardt Disease 1.Transl Vis Sci Technol2023
36918701A laser-induced mouse model of progressive retinal degeneration with central sparing displays features of parafoveal geographic atrophy.Sci Rep2023
36746120Associations with Non-Persistence with Intra-Vitreal Therapy for Neovascular Age-Related Macular Degeneration at 24 Months.Ophthalmologica2023
36572748Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy.Eye (Lond)2023
36757689Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.JAMA Ophthalmol2023
36207507Choroidal vascularity index and choroidal thickness: potential biomarkers in retinitis pigmentosa.Eye (Lond)2023
36167984The disparity between funding for eye research vs. the high cost of sight-loss in the UK.Eye (Lond)2023
31479010PERIPAPILLARY MITOCHONDRIAL RETINOPATHY SECONDARY TO A NOVEL MITOCHONDRIAL DNA MUTATION.Retin Cases Brief Rep2022
37645124The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients.Open Res Eur2022
35428639Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model.BMJ Open2022
35693873Evaluating a Causal Relationship between Complement Factor I Protein Level and Advanced Age-Related Macular Degeneration Using Mendelian Randomization.Ophthalmol Sci2022
35388619Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care.Acta Ophthalmol2022
36445968Impaired glutamylation of RPGR<sup>ORF15</sup> underlies the cone-dominated phenotype associated with truncating distal ORF15 variants.Proc Natl Acad Sci U S A2022
36643920A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative <i>CFI</i> variants in age-related macular degeneration.Front Immunol2022
36178237Pigmentary anomaly caused by mosaic 3q22.2q29 duplication.Clin Exp Dermatol2022
35954844The COVID-19 Pandemic and Ophthalmic Care: A Qualitative Study of Patients with Neovascular Age-Related Macular Degeneration (nAMD).Int J Environ Res Public Health2022
36326727Zfp503/Nlz2 Is Required for RPE Differentiation and Optic Fissure Closure.Invest Ophthalmol Vis Sci2022
36294292Patient Acceptability of Home Monitoring for Neovascular Age-Related Macular Degeneration Reactivation: A Qualitative Study.Int J Environ Res Public Health2022
35886953The Role of the Choroid in Stargardt Disease.Int J Mol Sci2022
36161843Associations with visual acuity outcomes after 12 months of treatment in 9401 eyes with neovascular AMD.BMJ Open Ophthalmol2022
35950019Multimodal Imaging of Vitelliform Lesions in Multiple Myeloma: A Case Report.Case Rep Ophthalmol2022
36191840Assessing the Pathogenicity of In-Frame CACNA1F Indel Variants Using Structural Modeling.J Mol Diagn2022
35980651Thinking Outside the Circle-The Potential Value of Ultra-Widefield Imaging.JAMA Ophthalmol2022
33495162Association of ambient air pollution with age-related macular degeneration and retinal thickness in UK Biobank.Br J Ophthalmol2022
35285476Rare complement factor I variants associated with reduced macular thickness and age-related macular degeneration in the UK Biobank.Hum Mol Genet2022
35314388Long-term Retinal Morphology and Functional Associations in Treated Neovascular Age-Related Macular Degeneration: Findings from the Inhibition of VEGF in Age-Related Choroidal Neovascularisation Trial.Ophthalmol Retina2022
35314386The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene.Ophthalmol Retina2022
35306732A High Fat "Western-style" Diet Induces AMD-Like Features in Wildtype Mice.Mol Nutr Food Res2022
35293574Generation of a Cone Photoreceptor-specific GNGT2 Reporter Line in Human Pluripotent Stem Cells.Stem Cells2022
34645968Can we classify central serous chorioretinopathy better? Yes we can.Eye (Lond)2022
34750590The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD.Eye (Lond)2022
34795415Intravitreal dexamethasone implant versus anti-vascular endothelial growth factor therapy combined with cataract surgery in patients with diabetic macular oedema: a systematic review with meta-analysis.Eye (Lond)2022
34326500Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study.Eye (Lond)2022
  • 1 - 50 of 330

Recommended Authors

Royal Victorian Eye and Ear Hospital
Career Start Year 2008
Number of shared co-authors 17
Singapore Eye Research Institute
Career Start Year 2007
Number of shared co-authors 10
University of Michigan (A.T.F.) ann arbor
Career Start Year 2007
Number of shared co-authors 9
Shiley Eye Institute, University of San Diego
Career Start Year 2007
Number of shared co-authors 3
Shiley Eye Institute, University of California
Career Start Year 2007
Number of shared co-authors 12
University Hospital Zurich and University of Zurich
Career Start Year 2006
Number of shared co-authors 26
University of Washington
Career Start Year 2006
Number of shared co-authors 7
Universidade Federal de Sao Paulo
Career Start Year 2006
Number of shared co-authors 4
The University of Sydney Save Sight Institute
Career Start Year 2005
Number of shared co-authors 22
National Eye Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 29
New York University School of Medicine, New York University Langone Health
Career Start Year 2004
Number of shared co-authors 5
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Career Start Year 2000
Number of shared co-authors 13
Unit on Clinical Investigation of Retinal Disease, National Eye Institute
Career Start Year 2000
Number of shared co-authors 19
Universite de Poitiers, INSERM 4 Department of Ophthalmology
Career Start Year 2000
Number of shared co-authors 38
University of California davis
Career Start Year 1998
Number of shared co-authors 3
Casey Eye Institute at Oregon Health & Science University (OHSU)
Career Start Year 1998
Number of shared co-authors 20
Yokohama City University Medical Center
Career Start Year 1998
Number of shared co-authors 8
Royal Perth Hospital
Career Start Year 1997
Number of shared co-authors 20
Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 10
Medical College of Wisconsin
Career Start Year 1994
Number of shared co-authors 10
Mayo Clinic
Career Start Year 1993
Number of shared co-authors 7
Wills Eye Hospital/Mid Atlantic Retina
Career Start Year 1992
Number of shared co-authors 26
Byers Eye Institute, Stanford University
Career Start Year 1990
Number of shared co-authors 14
Harvard Medical School
Career Start Year 1989
Number of shared co-authors 26
The University of Sydney Save Sight Institute
Career Start Year 1987
Number of shared co-authors 35
University of Illinois at Chicago
Career Start Year 1986
Number of shared co-authors 12
University of Wisconsin, Wisconsin EyeKor Inc.
Career Start Year 1981
Number of shared co-authors 19
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1981
Number of shared co-authors 35
Wilmer Eye Institute, Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 27
National Eye Institute, National Institutes of Health
Career Start Year 1962
Number of shared co-authors 33

Collaborators

NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital
Co-authored papers 38
Queen's University Belfast
Co-authored papers 25
Erasmus Medical Center
Co-authored papers 19
Carver College of Medicine, University of Iowa, USA Institute for Vision Research
Co-authored papers 18
Frimley Health NHS Foundation Trust
Co-authored papers 16
University of Oxford
Co-authored papers 15
Menzies Institute for Medical Research, University of Tasmania
Co-authored papers 14
NIHR Moorfields Biomedical Research Centre
Co-authored papers 12
Bristol Eye Hospital
Co-authored papers 12
Erasmus University Medical Center
Co-authored papers 12
Queen's University Belfast
Co-authored papers 12
Leeds Teaching Hospitals NHS Trust
Co-authored papers 11
University of Iceland
Co-authored papers 11
University of Bonn
Co-authored papers 11
University of Iceland
Co-authored papers 11
Co-authored papers 11
Institute of Ophthalmology, University College London
Co-authored papers 11
Lions Eye Institute, University of Western Australia
Co-authored papers 11
NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 10
deCODE genetics/Amgen Inc.
Co-authored papers 10
Regeneron Pharmaceuticals Inc.
Co-authored papers 10
University Medical Center Rotterdam
Co-authored papers 10
Flinders Medical Centre, Flinders University
Co-authored papers 10
Carver College of Medicine, University of Iowa
Co-authored papers 9
Co-authored papers 9
Cleveland Institute for Computational Biology, Case Western Reserve University
Co-authored papers 9
Hull York Medical School, University of York
Co-authored papers 9
Radboud University Medical Center
Co-authored papers 9
Co-authored papers 9
Erasmus University Medical Center
Co-authored papers 9